OpenAI, Sam Altman

Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...
Sam Altman's estranged younger sister, Ann Altman, filed suit against the OpenAI CEO on Monday, accusing him of childhood sexual abuse. On Tuesday afternoon, Sam Altman posted a statement on ...
"Cut your expectations by 100x," says Sam Altman, who also recently predicted superintelligence was just "a few thousand days ...